TY - BOOK AU - Kumar, Kaushik AU - Rao, Shiavax AU - Saleh, Nahar TI - A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis SN - 2168-8184 PY - 2022/// KW - IN PROCESS -- NOT YET INDEXED KW - MedStar Union Memorial Hospital KW - Internal Medicine KW - Internal Medicine Residency KW - Case Reports N2 - While rare, serious adverse effects including euglycemic diabetic ketoacidosis (EDKA) have been associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) use. We present an interesting case of SGLT2i-induced EDKA occurring two years after initiation of therapy. Most patients with EDKA recover with prompt recognition and treatment. Patient education about identifying early signs remains a cornerstone of early identification and response to SGLT2i-induced EDKA. Copyright © 2022, Rao et al UR - https://dx.doi.org/10.7759/cureus.30106 ER -